Scribe Biosciences Wins CYTO 2022 Technology Showcase
SAN FRANCISCO, July 7, 2022 /PRNewswire/ -- Scribe Biosciences has won the Technology Showcase at CYTO 2022, International Society for the Advancement of Cytometry's annual meeting. Scribe Biosciences is an early-stage company pioneering technologies to accelerate immunotherapy discoveries through linked functional and genomic profiling of single-cell interactions. Their powerful Microenvironment of Demand (MOD) single-cell interaction technology topped a field of 11 semifinalists to take home the award.
Characterization of interactions between immune cells and tumor cells is a key bottleneck for developers of immunotherapies, particularly for chimeric antigen receptor therapy (CAR-T) and T-cell receptor (TCR) therapy. Scribe's MOD technology can profile hundreds-of-thousands of immune ce...